Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -10.15x is in line with its 1-year average of -9.33x, near the low end of its 1-year range (-10.15x–-8.52x).
As of the fiscal period ended Tuesday, June 30, 2020.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-10.15x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.45x
median of 522 covered companies
CURRENT VS SECTOR MEDIAN
-57.31%
vs the sector median at left
Janux Therapeutics, Inc.
Market Cap
$1.03B
Interest Coverage Ratio
-10.15x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02B
Interest Coverage Ratio
0.23x
TTM Avg
0.32x
3Y Avg
0.27x
5Y Avg
0.27x
Market Cap
$1.03B
Interest Coverage Ratio
0.79x
TTM Avg
0.59x
3Y Avg
2.04x
5Y Avg
2.37x
Market Cap
$1.03B
Interest Coverage Ratio
-192.41x
TTM Avg
28.86x
3Y Avg
28.86x
5Y Avg
28.86x
Market Cap
$1.04B
Interest Coverage Ratio
-497.79x
TTM Avg
15.03x
3Y Avg
15.03x
5Y Avg
8.31x
Market Cap
$1.01B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$999.19M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.05B
Interest Coverage Ratio
-13.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$990.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | $1.03B | -10.15x | N/A | N/A | N/A |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 0.23x | 0.32x | 0.27x | 0.27x |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 0.79x | 0.59x | 2.04x | 2.37x |
| Immatics N.V. (IMTX)vs › | $1.03B | -192.41x | 28.86x | 28.86x | 28.86x |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | -497.79x | 15.03x | 15.03x | 8.31x |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | N/A | N/A | N/A | N/A |
| Vor Biopharma Inc. (VOR)vs › | $999.19M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -13.34x | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $990.42M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $984.44M | -8.69x | N/A | N/A | N/A |
Interest Coverage
-10.1x
Debt/Equity
0.02
Current Ratio
16.35
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2020-06-30 | -10.15x |
| 2020-03-31 | -8.52x |
